Drugs / Mtb72F/AS02
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00291889 | Jul 2004 → May 2005 | tuberculosis | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mtb72F/AS02 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00291889 ↗ |
| Modality | Vaccine | “candidate tuberculosis vaccine” NCT00291889 ↗ |